Wednesday April 1, 2020

Ireland’s EU drug-buying partnership secures first deal

The drug which the partnership agreed to fund is called Spinraza, which is used to treat Spinal Muscular Atrophy

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
15th July, 2018

The European partnership that aims to jointly negotiate pharmaceutical deals has reached its first collective pricing agreement.

The drug which the partnership agreed to fund is called Spinraza, which is used to treat Spinal Muscular Atrophy.

Spinraza is already being funded by the HSE in Ireland.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Susan Mitchell and Nadine O‘Regan keep you informed about the progress of coronavirus or Covid-19 in Ireland and abroad in a new podcast from the Business Post

Susan Mitchell | 11 hours ago

Shanghai resident Tracy Wang joins Nadine O‘Regan on The Coronavirus Ireland Podcast to provide an update on the state of the coronavirus pandemic in China

Nadine O’Regan | 1 day ago